Literature DB >> 28556774

Functional MRI examination of empathy for pain in people with schizophrenia reveals abnormal activation related to cognitive perspective-taking but typical activation linked to affective sharing.

Damien Vistoli1, Marie-Audrey Lavoie1, Stephanie Sutliff1, Philip L Jackson1, Amélie M Achim1.   

Abstract

BACKGROUND: Schizophrenia is associated with important disturbances in empathy that are related to everyday functioning. Empathy is classically defined as including affective (sharing others' emotions) and cognitive (taking others' cognitive perspectives) processes. In healthy individuals, studies on empathy for pain revealed specific brain systems associated with these sets of processes, notably the anterior middle cingulate (aMCC) and anterior insula (AI) for affective sharing and the bilateral temporoparietal junction (TPJ) for the cognitive processes, but the integrity of these systems in patients with schizophrenia remains uncertain.
METHODS: Patients with schizophrenia and healthy controls performed a pain empathy task while undergoing fMRI scanning. Participants observed pictures of hands in either painful or nonpainful situations and rated the level of pain while imagining either themselves (self) or an unknown person (other) in these situations.
RESULTS: We included 27 patients with schizophrenia and 21 healthy controls in our analyses. For the pain versus no pain contrast, patients showed overall typical activation patterns in the aMCC and AI, with only a small part of the aMCC showing reduced activation compared with controls. For the other versus self contrast, patients showed an abnormal modulation of activation in the TPJ bilaterally (extending to the posterior superior temporal sulcus, referred to as the TPJ/pSTS). LIMITATIONS: The design included an unnecessary manipulation of the visual perspective that reduced the number of trials for analysis. The sample size may not account for the heterogeneity of schizophrenia.
CONCLUSION: People with schizophrenia showed relatively intact brain activation when observing others' pain, but showed abnormalities when asked to take the cognitive perspectives of others.

Entities:  

Mesh:

Year:  2017        PMID: 28556774      PMCID: PMC5487273          DOI: 10.1503/jpn.160136

Source DB:  PubMed          Journal:  J Psychiatry Neurosci        ISSN: 1180-4882            Impact factor:   6.186


  55 in total

1.  A power primer.

Authors:  J Cohen
Journal:  Psychol Bull       Date:  1992-07       Impact factor: 17.737

Review 2.  The secret lives of experiments: methods reporting in the fMRI literature.

Authors:  Joshua Carp
Journal:  Neuroimage       Date:  2012-07-10       Impact factor: 6.556

3.  Empathy, depressive symptoms, and social functioning among individuals with schizophrenia.

Authors:  Amy C Abramowitz; Emily J Ginger; Jackie K Gollan; Matthew J Smith
Journal:  Psychiatry Res       Date:  2014-02-28       Impact factor: 3.222

4.  The neural substrate of human empathy: effects of perspective-taking and cognitive appraisal.

Authors:  Claus Lamm; C Daniel Batson; Jean Decety
Journal:  J Cogn Neurosci       Date:  2007-01       Impact factor: 3.225

5.  Empathy examined through the neural mechanisms involved in imagining how I feel versus how you feel pain.

Authors:  Philip L Jackson; Eric Brunet; Andrew N Meltzoff; Jean Decety
Journal:  Neuropsychologia       Date:  2005-09-06       Impact factor: 3.139

6.  Assessment of empathy in first-episode psychosis and meta-analytic comparison with previous studies in schizophrenia.

Authors:  Amelie M Achim; Rosalie Ouellet; Marc-André Roy; Philip L Jackson
Journal:  Psychiatry Res       Date:  2010-12-04       Impact factor: 3.222

7.  A functional magnetic resonance imaging study of social cognition in schizophrenia during an acute episode and after recovery.

Authors:  Kwang-Hyuk Lee; Wendy H Brown; Paul N Egleston; Russell D J Green; Tom F D Farrow; Michael D Hunter; Randolph W Parks; Iain D Wilkinson; Sean A Spence; Peter W R Woodruff
Journal:  Am J Psychiatry       Date:  2006-11       Impact factor: 18.112

8.  Self-rated and performance-based empathy in schizophrenia: the impact of cognitive deficits.

Authors:  George Konstantakopoulos; Panagiotis Oulis; Dimitris Ploumpidis; Panayiotis Patrikelis; Stavrina Nikitopoulou; George N Papadimitriou; Anthony S David
Journal:  Soc Neurosci       Date:  2014-06-27       Impact factor: 2.083

9.  Placebo analgesia and its opioidergic regulation suggest that empathy for pain is grounded in self pain.

Authors:  Markus Rütgen; Eva-Maria Seidel; Giorgia Silani; Igor Riečanský; Allan Hummer; Christian Windischberger; Predrag Petrovic; Claus Lamm
Journal:  Proc Natl Acad Sci U S A       Date:  2015-09-28       Impact factor: 11.205

10.  Some markers of mirroring appear intact in schizophrenia: evidence from mu suppression.

Authors:  William P Horan; Jaime A Pineda; Jonathan K Wynn; Marco Iacoboni; Michael F Green
Journal:  Cogn Affect Behav Neurosci       Date:  2014-09       Impact factor: 3.526

View more
  4 in total

1.  Nonsocial and social cognition in schizophrenia: current evidence and future directions.

Authors:  Michael F Green; William P Horan; Junghee Lee
Journal:  World Psychiatry       Date:  2019-06       Impact factor: 49.548

2.  Inter-subject phase synchronization differentiates neural networks underlying physical pain empathy.

Authors:  Lei Xu; Taylor Bolt; Jason S Nomi; Jialin Li; Xiaoxiao Zheng; Meina Fu; Keith M Kendrick; Benjamin Becker; Lucina Q Uddin
Journal:  Soc Cogn Affect Neurosci       Date:  2020-05-11       Impact factor: 3.436

3.  Application of the Graded Response Model to a Scale of Empathic Behavior.

Authors:  Sofía E Auné; Facundo J P Abal; Horacio F Attorresi
Journal:  Int J Psychol Res (Medellin)       Date:  2019 Jan-Jun

Review 4.  Overlapping and specific neural correlates for empathizing, affective mentalizing, and cognitive mentalizing: A coordinate-based meta-analytic study.

Authors:  Maria Arioli; Zaira Cattaneo; Emiliano Ricciardi; Nicola Canessa
Journal:  Hum Brain Mapp       Date:  2021-07-29       Impact factor: 5.038

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.